<DOC>
	<DOCNO>NCT02345447</DOCNO>
	<brief_summary>The purpose study study whether herbal-based medication superior placebo prevention acute otitis medium pre-school child upper respiratory tract infection .</brief_summary>
	<brief_title>Herbal-Based Medication v . Placebo Preventing Acute Otitis Media Children High Risk Recurrence</brief_title>
	<detailed_description>This prospective , control parallel-group comparison superiority Otovowen® . Patient identify screen patient card . Patients recurrent AOM age 12 59 month randomly assign either Otovowen® placebo . Randomization stratify age enrolment ( 12-35 versus 36-59 month ) . The observation period per subject 6 month . Data collection documentation perform weekly via online diary parents/legal representative ( ) investigator via eCRF . Patients see doctor baseline end study . Unscheduled visit case AOM severe URI disease initiate parents/legal representative ( ) . Study medication send patient/parents/legal representative ( ) randomization . administer first sign symptom URI ( e. g. elevate temperature , common cold , influenza , cough , sore throat , hoarse voice , frequent sneezing , run stuffy nose , sinusitis , fever , headache , etc . ) resolve ( maximally 8 week continuous application ) . AOM diagnose unscheduled visit accord criterion detail study protocol . An AOM consider resolve confirmation investigator . Compliance assess weigh content bottle IMPs .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Children least 3 episode acute otitis medium ( AOM ) within 12 month prior study inclusion document medical record . Diagnosis criterion AOM see study protocol parental write consent Ongoing acute otitis medium URI Current prophylaxis/treatment URI AOM Current use phytotherapeutic homeopathic agent secretolytic , antiinflammatory immune enhance property Use tympanostomy tube Chronic tympanic membrane perforation ( TMP ) Palatine cleft Parents/legal representative ( ) child unable follow study procedure , internet access willing use online diary weekly basis History hypersensitivity investigational drug ingredient . Systemic , severe well history uncontrolled chronic disease concurrent clinically significant illness , medical condition , investigator 's opinion , would contraindicate study participation compliance protocol mandate procedure . Simultaneous participation another clinical trial participation clinical trial involve investigational medicinal product within 30 day prior write informed consent trial .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>